Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

A case report of influenza-triggered RANBP2-associated acute necrotizing encephalomyelitis in an adult successfully treated with tocilizumab

  1. 1Division of Internal Medicine, University Hospital of Basel
  2. 2Department of Neurology, University Hospital and University of Basel
  3. 3Multiple Sclerosis Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel

Abstract

Here, we report a rare case of a 32-year-old patient presenting with a second episode of influenza A-triggered acute necrotizing encephalomyelitis (ANE) in the context of a Ran-binding protein 2 (RANBP2) -mutation, which was diagnosed after a previous influenza-triggered ANE at the age of eleven. Despite early treatment with corticosteroids, plasmapheresis and intravenous immunoglobulins (IVIG) no meaningful clinical improvement was observed during the first 6 weeks of treatment. As interleukin-6 (IL-6) levels were elevated in both blood and cerebrospinal fluid (CSF), additional therapy with tocilizumab was initiated, leading to clinical improvement from week 11 onward.

Related

  1. Macrophage Activation Syndrome Associated with Adult-onset Still's Disease Successfully Treated with Plasma Exchange and Canakinumab
    Wataru Kiyohara, Yuya Fujita, Muneyuki Hatta +12
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  2. Tocilizumab in refractory anti-synthetase syndrome-associated interstitial lung disease:a phenotype-stratified cohort study
    Hanbo Yang, Yongpeng Ge, Sizhao Li +9
    Respiratory ResearchPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  3. Atrophic tibial shaft nonunion in a young elite skier possibly associated with severe vitamin D deficiency and vitamin K insufficiency successfully treated with graft-free chipping and circular external fixation: a 10-year follow-up case report.
    Koji Nozaka, Naohisa Miyakoshi
    Journal of medical case reportsPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
  4. Disease-related readmission in anti-SRP-positive immune-mediated necrotizing myopathy: Incidence and exploratory associated factors in a retrospective cohort study
    Beibei Cui, Hongjiang Liu, Ruiting Liu +4
    Therapeutic Advances in Musculoskeletal DiseasePeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  5. Maternal risk factors associated with neonatal necrotizing enterocolitis: a meta-analysis and systematic review.
    Lindsey Burnham, Will Lichstein, Alex Lyford
    BMC pediatricsPeer-reviewedCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsEurope PMCDOAJ
BibTeX
@article{heusler2026case,
  title = {{A case report of influenza-triggered RANBP2-associated acute necrotizing encephalomyelitis in an adult successfully treated with tocilizumab}},
  author = {Marie-Anne Heusler and Sofia Sandgren and Jens Kuhle and Stephan Rüegg and Özgür Yaldizli and Cristina Granziera and Marten Trendelenburg and Severin Bausch},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1866407},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1866407/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - A case report of influenza-triggered RANBP2-associated acute necrotizing encephalomyelitis in an adult successfully treated with tocilizumab
AU  - Marie-Anne Heusler
AU  - Sofia Sandgren
AU  - Jens Kuhle
AU  - Stephan Rüegg
AU  - Özgür Yaldizli
AU  - Cristina Granziera
AU  - Marten Trendelenburg
AU  - Severin Bausch
PY  - 2026
DA  - 2026/10/28
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1866407
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1866407/full
AB  - Here, we report a rare case of a 32-year-old patient presenting with a second episode of influenza A-triggered acute necrotizing encephalomyelitis (ANE) in the context of a Ran-binding protein 2 (RANBP2) -mutation, which was diagnosed after a previous influenza-triggered ANE at the age of eleven. Despite early treatment with corticosteroids, plasmapheresis and intravenous immunoglobulins (IVIG) no meaningful clinical improvement was observed during the first 6 weeks of treatment. As interleukin-6 (IL-6) levels were elevated in both blood and cerebrospinal fluid (CSF), additional therapy with tocilizumab was initiated, leading to clinical improvement from week 11 onward.
SN  - 1664-3224
ER  -